lomustine and 18f-fluoroethyl-l-tyrosine

lomustine has been researched along with 18f-fluoroethyl-l-tyrosine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bauer, EK; Ceccon, G; Dunkl, V; Fink, GR; Galldiks, N; Henriksen, OM; Langen, KJ; Law, I; Lohmann, P; Muhic, A; Poulsen, HS; Schmidt, M; Shah, NJ; Steger, J; Stoffels, G; Tscherpel, C	1

Trials

1 trial(s) available for lomustine and 18f-fluoroethyl-l-tyrosine

Article	Year
Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:13 Topics: Adult; Aged; Bevacizumab; Disease Progression; Drug Interactions; Female; Glioblastoma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Survival Analysis; Treatment Outcome; Tyrosine	2018

Article

Year

Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine.

European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:13

Topics: Adult; Aged; Bevacizumab; Disease Progression; Drug Interactions; Female; Glioblastoma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Survival Analysis; Treatment Outcome; Tyrosine

2018